
Wockhardt Ltd. (WOCKPHARMA) Share Price Rises 2.68% to Rs 2,063
Updated: 18 Nov 2026 • 10:28 am
Posted by:

Wockhardt Share Price is higher today, with Wockhardt Ltd. trading at Rs 2,063.00, up 2.68% from the previous close, while its market capitalisation stands at Rs 32,575.56 crore. According to latest Univest data, the price event is confirmed, but no company-specific catalyst is established. For readers tracking Wockhardt Share Price Today, the move places the stock among the day’s notable gainers in Indian Stock Market trade, even though the verified data does not point to a fresh headline trigger. The immediate context is price action, valuation and sector positioning, so investors following Wockhardt Stock News can focus on what the numbers show rather than on speculation. In Wockhardt Share Price News, the key questions are how the stock traded during the day, how its fundamentals compare with peers, and what the latest Univest figures suggest about its place in Healthcare.
Wockhardt Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 2,063 |
| Previous Close | Rs 2,009.25 |
| Today's Move | Rs 53.75 (+2.68%) |
| Open | Rs 2,009.3 |
| High | Rs 2,065 |
| Low | Rs 2,005 |
| Market Capitalisation | Rs 32,575.56 crore |
| Market Cap Category | Large Cap |
Wockhardt Ltd. (WOCKPHARMA) rose to Rs 2,063 from the previous close of Rs 2,009.25, a move of Rs 53.75 or 2.68%. The stock opened at Rs 2,009.3, reached a high of Rs 2,065, recorded a low of Rs 2,005.
Wockhardt Share Price moved higher by Rs 53.75 today, or 2.68%, with the stock trading at Rs 2,063.00. The move began near the previous close of Rs 2,009.25 and the day open of Rs 2,009.30, then touched a high of Rs 2,065.00 and a low of Rs 2,005.00. This makes the Wockhardt Share Price Today action easy to read: the stock stayed close to its starting point before advancing toward the upper end of the day’s range.
For Wockhardt Share Price Live tracking, the useful facts are straightforward. The current level, previous close, open, high and low give a clear price frame for the session. Wockhardt Share Price Update watchers can also note that the market capitalisation remained Rs 32,575.56 crore, which keeps the move within a broader valuation context. According to latest Univest data, this is a price rise, not a call on direction. The next section explains whether the fundamentals add support to the current Wockhardt Share Price narrative.
Wockhardt Ltd. (WOCKPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 32,575.56 crore |
| P/E Ratio | 79.64x |
| P/B Ratio | 6.33x |
| ROE | 4.29% |
| ROCE | 6.79% |
| EPS | Rs 25.23 |
| Book Value Per Share | Rs 317.41 |
| Dividend Yield | 0% |
Wockhardt Ltd. (WOCKPHARMA) fundamental metrics show P/E 79.64x, P/B 6.33x, ROE 4.29%, ROCE 6.79%. These figures provide context only and are not a buy or sell signal.
Wockhardt Ltd. has a market capitalisation of Rs 32,575.56 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 79.64x, P/B at 6.33x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.29% and ROCE of 6.79%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 25.23, book value per share of Rs 317.41, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.01x, median ROE of 11.33%, median ROCE of 13.1%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 79.64x |
| Benchmark Median P/E | 31.01x |
| Benchmark Average P/E | 58.7x |
| Benchmark P/E Range | 2.75x to 1,425.63x |
| Company P/B Ratio | 6.33x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 4.29% |
| Benchmark Median ROE | 11.33% |
| Company ROCE | 6.79% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 32,575.56 crore |
| Benchmark Median Market Cap | Rs 791.38 crore |
Wockhardt Ltd. (WOCKPHARMA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 79.64x, which is above the benchmark median of 31.01x, a difference of +156.82%. On its own, the P/E gap is a valuation reference point, not a trading call.
Wockhardt Ltd. (WOCKPHARMA) has a ROE of 4.29%, which is below the benchmark median of 11.33%, a difference of -62.14%. Wockhardt Ltd. (WOCKPHARMA) has a ROCE of 6.79%, which is below the benchmark median of 13.1%, a difference of -48.17%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,47,943.84 | 40.92 | 5.03 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,94,962.14 | 87.74 | 16.4 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,78,390.62 | 83.65 | 9.67 | 26.76 | 19.27 |
| Laurus Labs Ltd. | LAURUSLABS | 1,19,789.92 | 94.36 | 20.86 | 18.31 | 18.2 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,18,603.21 | 28.7 | 4.31 | 19.69 | 21.39 |
Wockhardt Ltd. (WOCKPHARMA) has a P/E ratio of 79.64x compared with the displayed peer median of 83.65x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 4.29% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 6.79% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Wockhardt Ltd. (WOCKPHARMA) has a market capitalisation of Rs 32,575.56 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Wockhardt
- Wockhardt Share Price rose 2.68% to Rs 2,063.00, keeping Wockhardt Share Price Today in focus.
- The stock’s market capitalisation stands at Rs 32,575.56 crore, which frames the move in a larger Healthcare context.
- Wockhardt Share Price carries a P/E of 79.64 and a P/B of 6.33, both above the same-industry midpoint.
- ROE of 4.29% and ROCE of 6.79% are key return metrics in Wockhardt Fundamental Analysis.
- Peer comparison shows Wockhardt Share Price at a higher earnings multiple than several listed pharma names.
About Wockhardt Ltd.
Wockhardt Ltd. operates in Healthcare and belongs to the Pharmaceuticals & Drugs industry. The company is known for pharmaceutical operations, and the latest Univest figures place it within a large listed universe of 200 same-industry companies in the latest Univest figures. For Wockhardt Share Price, the main business context today is not a new company narrative but the market’s response to a higher trade level against a defined sector backdrop.
Wockhardt Share Price Today should therefore be read in connection with the company’s valuation profile, return ratios and industry standing. The stock’s book value of Rs 317.41 and EPS of Rs 25.23 provide a basic earnings-and-equity reference point, while the 0 dividend yield shows no current income layer in the visible data. Wockhardt Stock Analysis remains best anchored in these facts rather than in assumptions about future moves.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is Wockhardt Share Price rising today?
Ans. Wockhardt Share Price is rising today because the stock is trading 2.68% higher at Rs 2,063.00. According to Univest data, the price event is confirmed, but no company-specific catalyst is established.
What is Wockhardt Share Price today?
Ans. Wockhardt Share Price today is Rs 2,063.00. The stock is up Rs 53.75 from the previous close of Rs 2,009.25, which places Wockhardt Share Price Today in positive territory.
What is Wockhardt market capitalisation?
Ans. Wockhardt market capitalisation stands at Rs 32,575.56 crore. That size measure helps frame Wockhardt Share Price in the broader Healthcare sector and the Pharmaceuticals & Drugs industry. The company operates in the Healthcare sector.
What does Wockhardt Fundamental Analysis show?
Ans. Wockhardt Fundamental Analysis shows a P/E ratio of 79.64, P/B of 6.33, ROE of 4.29%, ROCE of 6.79%, EPS of Rs 25.23 and book value of Rs 317.41. These metrics shape Wockhardt Share Price analysis.
How does Wockhardt compare with pharma peers?
Ans. Wockhardt Share Price has a higher P/E than peers such as Sun Pharma, Zydus Lifesciences, Dr. Reddy’s, Cipla and Lupin, but lower ROE and ROCE than the peer group shown in Univest data.
What is Wockhardt Share Price compared with the day’s range?
Ans. Wockhardt Share Price traded between Rs 2,005.00 and Rs 2,065.00 today. The stock is now close to the day’s high, which gives Wockhardt Share Price Today a firm intraday position.
Is Wockhardt valued above the industry benchmark?
Ans. Wockhardt Share Price trades above the industry median P/E of 31.01 and median P/B of 2.88 for Pharmaceuticals & Drugs. The latest Univest figures show a richer valuation than the benchmark midpoint.
Does Wockhardt pay a dividend?
Ans. Wockhardt dividend yield is 0% in the latest Univest figures. That means Wockhardt Share Price is not supported by a current yield profile, so investors are mainly reading the stock through valuation and return ratios.
Track Wockhardt Share Price on Univest
Use Wockhardt Ltd. (WOCKPHARMA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors tracking Wockhardt Share Price can use Univest to follow the latest share price, key valuation ratios, market capitalisation, 52-week levels and company insights in one place. For Wockhardt Share Price Today, Univest keeps the focus on verified price action, fundamentals and sector comparison.
Recent Articles

Tata Technologies Share Price Jumps 7% to Rs 704 as FY30 Plan Targets $1.1 to $1.3 Billion Revenue, With JPMorgan's Rs 660 Target Below the Market
19 November 2026

Physicswallah Share Price Target: Motilal Oswal Holds Rs 200 After FY30 Guidance as the Stock Closes 6% Higher at Rs 135.98
19 November 2026

Religare Enterprises (RELIGARE) Share Price Rises 5.09% to Rs 232.25
19 November 2026

Universus Photo Imagings Ltd. Hits Upper Circuit for the 2nd Straight Session on NSE, 19 November 2026
19 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Tata Technologies Share Price Jumps 7% to Rs 704 as FY30 Plan Targets $1.1 to $1.3 Billion Revenue, With JPMorgan's Rs 660 Target Below the Market
Physicswallah Share Price Target: Motilal Oswal Holds Rs 200 After FY30 Guidance as the Stock Closes 6% Higher at Rs 135.98
Religare Enterprises (RELIGARE) Share Price Rises 5.09% to Rs 232.25
Universus Photo Imagings Ltd. Hits Upper Circuit for the 2nd Straight Session on NSE, 19 November 2026
HGS (INDIA) LIMITED Hits Upper Circuit on NSE, 19 November 2026

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





